Murat Gültekin

Er wurde 1977 in Sivas geboren. Grund-, Mittelschule und Gymnasium schloss er jeweils als Schulbester ab. 1995 erzielte er in der Universitätsaufnahmeprüfung eine Spitzenplatzierung und wurde an der englischsprachigen Medizinischen Fakultät der Universität Hacettepe aufgenommen. 2001 schloss er mit Auszeichnung ab und gehörte im selben Jahr in der Facharztprüfung zu den besten Zehn in der Türkei und erhielt einen Platz in der Abteilung für Frauenheilkunde und Geburtshilfe der Universität Hacettepe. Während der Assistenzzeit arbeitete er im Bereich Gynäkologische Onkologie. 2009 erhielt er das von der Europäischen Union akkreditierte Zertifikat als gynäkologischer Onkologe und begann im selben Jahr seinen Dienst in der Abteilung für Krebs. In den Jahren 2010–2011 war er Experte der Parlamentarischen Untersuchungskommission der Großen Türkischen Nationalversammlung (T.B.M.M.), die zur Untersuchung von Krebserkrankungen und zur Festlegung erforderlicher Maßnahmen eingesetzt wurde. 2012 erhielt er den Titel Assoz. Prof. 2014 wurde er zum stellvertretenden Vorsitzenden des Vorstands der Europäischen Gesellschaft für Gynäkologische Onkologie (ESGO) gewählt. Von 2012 bis 2017 war er Leiter der Abteilung für Krebs im Gesundheitsministerium. Er gehörte dem Team an, das das nationale HPV-DNA-Screening, die zentrale Befundung beim Brustkrebs sowie gemeindebasierte Palliativversorgungsmodelle mit mobilen Krebs-Screening-Geräten erstmals sowohl in unserem Land als auch weltweit umsetzte. Im Bereich Gynäkologische Onkologie hat er über 100 internationale Artikel veröffentlicht und über 200 internationale Vorträge gehalten. Derzeit ist er Herausgeber des weltweit wichtigsten Referenzwerks in diesem Bereich. Er gehört den Vorständen internationaler Institutionen und Organisationen an, darunter WHO, EU, IARC, ANCCA, APOCP, CentEast GOG, ENGAGe, ENYGO, ENPIGo, MECC, ESGO und die Koalition der Schwarzmeerländer. 2018 wurde er Internationaler Berater des Eradikationsprogramms für Gebärmutterhalskrebs der Weltgesundheitsorganisation. Im selben Jahr entwickelte er weltweit erstmals das HPV-Help-Taschenprogramm. Zuletzt ist er einer der 5 Experten, die von den Parlamentariern der Arbeitsgruppe zur Bekämpfung von HPV und Gebärmutterhalskrebs im Europäischen Parlament ausgewählt wurden.

Derzeit arbeitet er weiterhin in der Abteilung für Frauenheilkunde und Geburtshilfe der Universität Hacettepe. Er ist verheiratet und hat zwei Kinder. Er besitzt Zertifikate in fortgeschrittener Statistik und Lehrkompetenzen und spricht gut Englisch und Deutsch.

1. ASO Visual Abstract: Perioperative Risk Stratification in Surgically Treated Endometrial Cancer: The Impact of Nutritional Status and Comorbidity Burden on Morbidity and SurvivalCENGİZ M., Zaim O. C., Temiz B. E., KARAKILINÇ A., Yavuz O. A., Ege H. V., et al.Annals of surgical oncology, cilt.33, sa.9, ss.8390-8391, 2026 (SCI-Expanded, Scopus)
2. Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysisCENGİZ M., Zaim O. C., Temiz B. E., Grigore M., GÜLTEKİN M.Current opinion in oncology, cilt.38, sa.5, ss.393-405, 2026 (SCI-Expanded, Scopus)
3. Concomitant Metabolic Bariatric Surgery and Minimally Invasive Hysterectomy for Endometrial Cancer or Endometrial Intraepitelhelial Neoplasia in Patients with Severe Obesity: A Systematic Review of Early ExperienceCENGİZ M., Ege H. V., Zaim O. C., Temiz B. E., AKGÖR U., GÜLTEKİN M., et al.Obesity Surgery, cilt.36, sa.9, ss.4924-4936, 2026 (SCI-Expanded, Scopus)
4. European Society of Gynecological Oncology Consensus Statement on the prevention of surgical complications in gynecologic oncologyHaidopoulos D., Zapardiel I., Planchamp F., Thomakos N., Kyrgiou M., Grigore M., et al.International Journal of Gynecological Cancer, cilt.36, sa.9, 2026 (SCI-Expanded, Scopus)
5. Survival Impact of Bevacizumab According to Chemotherapy Response Score in Advanced High-Grade Serous Ovarian Carcinoma Treated with Neoadjuvant ChemotherapyEge H. V., TUNCER H., AKGÖR U., GÜLTEKİN M., TUNCER Z. S., BAŞARAN D.Cancers, cilt.18, sa.18, 2026 (SCI-Expanded, Scopus)
6. Perioperative Risk Stratification in Surgically Treated Endometrial Cancer: The Impact of Nutritional Status and Comorbidity Burden on Morbidity and SurvivalCENGİZ M., Zaim O. C., Temiz B. E., KARAKILINÇ A., Yavuz O. A., Ege H. V., et al.Annals of Surgical Oncology, cilt.33, sa.9, ss.8358-8368, 2026 (SCI-Expanded, Scopus)
7. Cancer Risk Profile of the Levonorgestrel-Releasing Intrauterine Device: A Narrative ReviewAKGÖR U., Temiz B. E., EGE H. V., Ellis L. B., Bowden S., Kyrgiou M., et al.Cancers, cilt.18, sa.15, 2026 (SCI-Expanded, Scopus)
8. European Society of Gynaecological Oncology/European Network of Gynaecological Advocacy Groups Position on risk-based cervical cancer screeningJoura E., Chatzistamatiou K., GÜLTEKİN M., Sehouli J., Toth I., Toth R.International Journal of Gynecological Cancer, cilt.36, sa.8, 2026 (SCI-Expanded, Scopus)
9. ESGO Consensus Statement on endometrial cancer prevention, risk reduction strategies, and management of women with Lynch syndromeMarchetti C., GÜLTEKİN M., Sassu C. M., Planchamp F., Ellis L. B., Bowden S. J., et al.European Journal of Cancer, cilt.240, 2026 (SCI-Expanded, Scopus)
10. High-Risk Human Papillomavirus Clearance with a Coriolus versicolor–Based Vaginal GelTUNCER H., Hajiyeva S., Serin B. G., ATAKUL M. O., GÜNEŞ A. C., Onat T., et al.Diseases, cilt.14, sa.5, 2026 (ESCI, Scopus)
11. A unique triple association: intravascular leiomyomatosis, benign metastasizing leiomyoma, and early-stage endometrial carcinomaÇimen T. B., CENGİZ M., Zaim O. C., Temiz B. E., GÜLTEKİN M., AKGÖR U.AJOG Global Reports, cilt.6, sa.2, 2026 (ESCI, Scopus)
12. Building cervical cancer screening capacity in low-resource settings: lessons from Techiman, GhanaPan T. L., Friko I., Mwinbe-Ere Der V., GÜLTEKİN M., Taumberger N.International Journal of Gynecological Cancer, cilt.36, sa.5, 2026 (SCI-Expanded, Scopus)
13. International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical ScreeningYilmaz E., Murray G. L., Balgovind P., Garland S. M., Pereira R., Vanden Broeck D., et al.Journal of Medical Virology, cilt.98, sa.5, 2026 (SCI-Expanded, Scopus)
14. Molecular triage and radiotherapy in high-intermediate-risk endometrial cancer: are both necessary?Dursun P., Ozdemir D., GÜLTEKİN M.International Journal of Gynecological Cancer, cilt.36, sa.5, 2026 (SCI-Expanded, Scopus)
15. Association of Oral Papivir/Pavirona® Supplementation with HPV DNA ClearanceGÜNGÖR SERİN B., Temiz B. E., TUNCER H., ATAKUL M. O., GÜNEŞ A. C., Onat T., et al.Viruses, cilt.18, sa.4, 2026 (SCI-Expanded, Scopus)
16. Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma: The European Society of Gynaecological Oncology Consensus StatementsPiek J. M., Schauwaert J., Ellis L. B., Zapardiel I., Planchamp F., Koblos K., et al.JAMA, cilt.335, sa.10, ss.894-902, 2026 (SCI-Expanded, Scopus)
17. A Comprehensive Overview of the Clinical, Electrophysiological, and Neuroimaging Features of BPAN: Insights From a New Case SeriesSusgun S., Kizek O., UĞUR İŞERİ S. A., Kamaci I., ELMALI YAZICI A. D., Iscen P., et al.Annals of Clinical and Translational Neurology, cilt.13, sa.3, ss.453-465, 2026 (SCI-Expanded, Scopus)
18. Prophylactic HPV Vaccination in Gynaecological Practice: Recommendations, Practices, and Challenges Reported in the ESGO-PERCH HPV SurveyKacperczyk-Bartnik J., Arbyn M., Denoël S., Bilir E., Dhollander N., Razumova Z., et al.Vaccines, cilt.14, sa.3, 2026 (SCI-Expanded, Scopus)
19. HPV Exposure in the Gynecological Practice: Time to Call It an Occupational Disease? A Systematic Review of the Literature and ESGO Experts’ OpinionEge H. V., Temiz B. E., Grigore M., Burney Ellis L., Bowden S. J., Lopez-Cavanillas B., et al.Vaccines, cilt.14, sa.2, 2026 (SCI-Expanded, Scopus)
20. Human Papillomavirus in Reproductive Health and Pregnancy: Clinical Implications, Outcomes, and a Comprehensive Review of VaccinationEge H. V., Goutallier C., Ellis L. B., Hajj H. E., Kacperczyk-Bartnik J., Temiz B. E., et al.Vaccines, cilt.14, sa.2, 2026 (SCI-Expanded, Scopus)
21. Human Papillomavirus Testing and Size of CIN3: Implications for the Risk of Microinvasive Cervical CarcinomaPreti M., Biggeri A., Ronco G., Kyrgiou M., Rizzolo R., Armaroli P., et al.Cancers, cilt.18, sa.3, 2026 (SCI-Expanded, Scopus)
22. Attitudes in Patients With Prodromal and Overt α-Synucleinopathy Toward Risk Disclosure: A Nationwide RegistryYILMAZ R., Çakan G. C. Y., Karadağ Y. S., Hoş Ü. D., Acarer A., Kabeloğlu V., et al.Movement Disorders Clinical Practice, 2026 (SCI-Expanded, Scopus)
23. Vulvar Bazal Hücreli Karsinom: Dört Olguluk Bir Seri ve Narratif DerlemeÇİMEN T. B., ZAİM O. C., TEMİZ B. E., GÜNEŞ A. C., GÜLTEKİN M.TÜRK JİNEKOLOJİK ONKOLOJİ DERGİSİ, cilt.25, sa.3, ss.130-135, 2026 (Hakemli Dergi)
24. Advancing cervical cancer prevention in Africa: ESGO's strategic initiatives and collaborative effortsEl Hajj H., Hemida R., Taumberger N., Friko I., Gassama O., Ramogola-Masire D., et al.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.36, sa.1, 2026 (SCI-Expanded, Scopus)
25. Recurrence of Adult Granulosa Cell Tumors: The Factors Affecting Secondary Recurrence and Survival After RecurrenceEGE H. V., Bagaran D., GÜLTEKİN M., ÖZGÜL N., Boran N., KOÇ S., et al.Journal of Cancer, cilt.17, sa.3, ss.637-645, 2026 (SCI-Expanded, Scopus)
26. Predictors of lymphocyst development following lymphadenectomy in patients with gynecologic cancerKaratas E., Salman M. C., BAŞARAN D., AKGÖR U., GÜLTEKİN M., Ozgul N.International Journal of Gynecology and Obstetrics, cilt.172, sa.1, ss.318-326, 2026 (SCI-Expanded, Scopus)
27. Robotic-assisted neovaginal creation: stepwise approach to the Davydov technique in a patient with Mayer-Rokitansky-Kuster-Hauser syndromeTUNCER H., EGE H. V., AKGÖR U., GÜLTEKİN M., TUNCER Z. S., ÖZGÜL N., et al.FERTILITY AND STERILITY, cilt.123, sa.5, ss.907-909, 2025 (SCI-Expanded, Scopus)
28. Multivisceral Resection and Abdominal Wall Reconstruction for Recurrent Endometrial CancerCengiz M., EGE H. V., AKGÖR U., ÖZGÜL N., GÜLTEKİN M., BAŞARAN D.ANNALS OF SURGICAL ONCOLOGY, cilt.32, sa.3, ss.2223, 2025 (SCI-Expanded, Scopus)
29. Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statementKyrgiou M., Bowden S. J., Ellis L. B., Hammer A., Lyons D., Freeman-Wang T., et al.LANCET ONCOLOGY, cilt.26, sa.3, 2025 (SCI-Expanded, Scopus)
30. Planning and performing simultaneous bariatric surgery and robotic hysterectomy in a super-obese patient with endometrial cancerEge H. V., Cengiz M., AKKAPULU N., AKGÖR U., GÜLTEKİN M., Ozgul N., et al.JOURNAL OF GYNECOLOGIC ONCOLOGY, cilt.36, sa.2, 2025 (SCI-Expanded, Scopus)
31. Prevention of gynecological cancers: cervical cancer screening in Turkey: a role model for the worldAKGÖR U., Temiz B. E., GÜLTEKİN M.CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, cilt.37, sa.1, ss.30-36, 2025 (SCI-Expanded, Scopus)
32. Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO) , International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) consensus statementsPreti M., Lewis F., Carcopino X., Bevilacqua F., Ellis L. B., Halonen P., et al.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.35, sa.1, 2025 (SCI-Expanded, Scopus)
33. Implementing High-Risk Human Papillomavirus Self-Sampling for Cervical Cancer Screening in Ghana: A Study (CarciSCAN) ProtocolTaumberger N., Friko I., Der V. M., Ellis L. B., Shearer A. M., Bowden S. J., et al.CANCER CONTROL, cilt.32, 2025 (SCI-Expanded, Scopus)
34. FDA approves the first HPV self-collection solutionsBilir E., Sacinti K. G., Kacperczyk-Bartnik J., GÜLTEKİN M.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.34, sa.11, ss.1833, 2024 (SCI-Expanded, Scopus)
35. The effect of age or menopausal status on elimination in the group receiving HPV vaccineTUNCER H., GÜNGÖR SERİN B., Cengiz M., EGE H. V., AKGÖR U., BAŞARAN D., et al.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, sa.SUPPL_3, 2024 (SCI-Expanded, Scopus)
36. Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group StudyAKGÖR U., BAŞARAN D., Meydanli M. M., Kuscu E., Demirkiran F., TOPUZ S., et al.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.34, ss.1382-1388, 2024 (SCI-Expanded, Scopus)
37. Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screeningArbyn M., Cuschieri K., Bonde J., Schuurman R., Cocuzza C., Broeck D. V., et al.JOURNAL OF MEDICAL VIROLOGY, cilt.96, sa.9, 2024 (SCI-Expanded, Scopus)
38. Evaluation of Endocervical Curettage in Colposcopy in the Turkish Cervical Cancer Screening ProgramAKGÖR U., ÖZGÜL N., Gunes A. C., Turkyilmaz M., GÜLTEKİN M.JOURNAL OF CLINICAL MEDICINE, cilt.13, sa.15, 2024 (SCI-Expanded, Scopus)
39. Case studies on the progress of cervical cancer screening programs in Bhutan, India, and TurkiyeBurdier F. R., Bolio A., Abraham P., Pimple S., Franco E. L., Pempa P., et al.VACCINE, cilt.42, sa.18, 2024 (SCI-Expanded, Scopus)
40. Ethanol Sclerotherapy in the Management of Ovarian Endometrioma: Technical Considerations for Catheter- and Needle-Directed SclerotherapyAzizova A., ÇİFTÇİ T. T., GÜLTEKİN M., ÜNAL E., AKHAN O., BOZDAĞ G., et al.CardioVascular and Interventional Radiology, cilt.47, sa.7, ss.891-900, 2024 (SCI-Expanded, Scopus)
41. Primary vs. interval cytoreduction for high-grade serous ovarian cancer: oncological outcomes from a retrospective study at a single tertiary referral centerZAİM O. C., ÖZGÜL N., SALMAN M. C., EGE H. V., BAŞARAN D., Geredelioglu Y., et al.EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, sa.3, ss.138-153, 2024 (SCI-Expanded)
42. Critical review of the SHAPE trial SHAPE çalışmasının eleştirel incelemesiDursun P., GÜLTEKİN M.TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, cilt.21, sa.2, ss.131-132, 2024 (ESCI, Scopus, TRDizin)
43. Lower Limb Lymphedema Awareness among Gynecological Cancer Patients: An International Survey Supported by the European Network of Gynecological Cancer Advocacy Groups (ENGAGe) GroupHaidopoulos D., Pergialiotis V., Papageorgiou M., Halaska M. J., Maxova K., Ulrich E., et al.CANCERS, cilt.16, sa.8, 2024 (SCI-Expanded, Scopus)
44. Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statementMitra A., GÜLTEKİN M., Burney Ellis L., Bizzarri N., Bowden S., Taumberger N., et al.The Lancet Microbe, cilt.5, sa.3, 2024 (SCI-Expanded, Scopus)
45. Oncological surgery is associated with increased morbidity but not mortality in elderly patients undergoing gynecological proceduresCengiz M., EGE H. V., KARAKILINÇ A., ADALI İ., Akdeniz E., ÖZGÜL N., et al.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, sa.SUPPL_1, 2024 (SCI-Expanded, Scopus)
46. Is vaginal cytology necessary in the follow-up of endometrial cancer?TEMİZ B. E., EGE H. V., Atakul O., Sinci U., Cengiz M., AKGÖR U., et al.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, sa.SUPPL_1, 2024 (SCI-Expanded, Scopus)
47. Highlights from the 24th European Congress on Gynaecological Oncology in Istanbul: an ENYGO-IJGC Fellows compilationAngeles M. A., De Vitis L. A., Cucinella G., Bonaldo G., Bizzarri N., Agusti N., et al.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.34, ss.190-196, 2024 (SCI-Expanded, Scopus)
48. Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening programGunes A. C., ÖZGÜL N., Turkyılmaz M., Kara F., Unlu F., Ayhan A., et al.Cancer Medicine, cilt.12, sa.24, ss.21751-21760, 2023 (SCI-Expanded, Scopus)
49. Building research competency across low and middle resource settings: an ENGOT initiative and NOGGO mentorship program at the ESGO 2022 in BerlinNasser S., Bilir E., David A., GÜLTEKİN M., Sehouli J.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.34, sa.1, ss.163-164, 2023 (SCI-Expanded, Scopus)
50. OUR SINGLE-CENTER EXPERIENCE WITH COLPOSCOPY IN CASES OF POSTCOITAL BLEEDINGEGE H. V., GÜNGÖR B., DİŞCİOĞLU N., ÖZGÜL N., BAŞARAN D., GÜLTEKİN M.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023 (SCI-Expanded, Scopus)
51. IS FERTILITY PRESERVING APPROACH RISKY IN BORDERLINE OVARIAN TUMOR?EGE H. V., TUNCER H., ÖZGÜL N., BAŞARAN D., GÜLTEKİN M.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023 (SCI-Expanded, Scopus)
52. EVALUATION OF CLINICAL AND PATHOLOGICAL DATA OF PATIENTS WITH ENDOMETRIUM CANCER WITH MICROSATELLIT INSTABILITYSahna O. C., EGE H. V., SALMAN M. C., GÜLTEKİN M., Akgor U., ÖZGÜL N.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023 (SCI-Expanded, Scopus)
53. IS THE TUMOR SIZE EFFECTIVE FOR LYMPHADENECTOMY DECISION IN EARLY-STAGE ENDOMETRIAL CANCER?ARTIRAN N., KAMANİ M. O., Sinci U., EGE H. V., ÖZGÜL N., GÜLTEKİN M.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023 (SCI-Expanded, Scopus)
54. TRIAGING OF HPV PCR-BASED CERVICAL CANCER SCREENING RESULTS BY INNOVATIVE BIOMARKER MRNA-BASED ASSAYS FOR REDUCTION OF OVER-REFERRAL AND OVERTREATMENTKaufmann A. M., Leenders W., Skof A. S., Schreckenberger C., Ullrich A., Sehouli J., et al.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023 (SCI-Expanded, Scopus)
55. Quality assurance in human papillomavirus testing for primary cervical screeningCuschieri K., Fellner M. D., Arroyo Mühr L. S., Padalko E., Correa R. M., Dillner J., et al.International Journal of Gynecological Cancer, cilt.33, sa.5, ss.802-811, 2023 (SCI-Expanded, Scopus)
56. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasiaKesic V., Carcopino X., Preti M., Vieira-Baptista P., Bevilacqua F., Bornstein J., et al.International Journal of Gynecological Cancer, cilt.33, sa.4, ss.446-461, 2023 (SCI-Expanded, Scopus)
57. ESGO Prevention Committee opinion: Is a single dose of HPV vaccine good enough?KAMANİ M. O., Kyrgiou M., Joura E., Zapardiel I., Grigore M., Arbyn M., et al.International Journal of Gynecological Cancer, cilt.33, sa.4, ss.462-464, 2023 (SCI-Expanded, Scopus)
58. Comparison of Neoadjuvant Chemotherapy Plus Interval Debulking Surgery and Primary Debulking Surgery in Patients with Stage III and IV Ovarian Carcinoma: A Multicenter Real Life ExperienceYilmaz M., Başak M., Özyükseler D. T., Yildirim M. E., ARIK Z., SALMAN M. C., et al.Turk Onkoloji Dergisi, cilt.38, sa.3, ss.323-332, 2023 (ESCI, Scopus, TRDizin)
59. OPEC study: An international multicenter study of ovarian preservation in endometrial cancersAKGÖR U., AYHAN A., Shushkevich A., Ozdal B., Angelou K., Akbayir O., et al.INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, cilt.159, sa.2, ss.550-556, 2022 (SCI-Expanded, Scopus)
60. Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention CommitteeTaumberger N., Joura E. A., Arbyn M., Kyrgiou M., Sehouli J., Gultekin M.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.32, sa.10, ss.1316-1320, 2022 (SCI-Expanded, Scopus)

All 139 on AVESİS →

1. Two-Dimensional Array-Based Mechanical Quality Control of High-Dose-Rate Brachytherapy Treatment UnitBİLTEKİN F., YEĞİNER M., DOĞAN A., GÜLTEKİN M., ÖZYİĞİT G., YILDIZ F.58th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Massachusetts, Amerika Birleşik Devletleri, 25 - 28 Eylül 2016, cilt.96, (Özet Bildiri)
2. Radiation Therapy Results of Patients With Adenoid Cystic CarcinomaGÜLTEKİN M., CENGİZ M., Sari S. Y., HOŞAL Ş., YAZICI G., SÜSLÜ N., et al.57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Kuzey Mariana Adaları, 18 - 21 Ekim 2015, cilt.93, (Özet Bildiri)
3. The Dosimetric Impact of Implants on the Spinal Cord Dose in Stereotactic Body Radiation TherapyYAZICI G., Yedekci Y., Yucekul A., Birgi S., Demirkiran G., GÜLTEKİN M., et al.56th Annual Meeting of the American-Society-for-Radiation-Oncology, San-Francisco, Kostarika, 14 - 17 Eylül 2014, cilt.90, (Özet Bildiri)
4. Metaplastic breast carcinoma: A heterogeneous diseaseGÜLTEKİN M., Eren G., Babacan T., Yazici G., Hurmuz P., Yildiz F., et al.European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri)
5. Robotic Stereotactic Radiotherapy in the Management of Pediatric Patients With Benign and Malign LesionsGÜLTEKİN M., Cengiz M., Ozyigit G., Sezen D., Yildiz F., Gurkaynak M., et al.European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47, (Özet Bildiri)
6. Comparison of FIGO 1988 and 2008 Classifications For Endometrial CarcinomaÖZYİĞİT G., GÜLTEKİN M., YILDIZ F., Beyaz H., HAYRAN K. M., Kose F., et al.European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47, (Özet Bildiri)
7. Postpartum Fitz-Hugh–Curtis Syndrome Following Cesarean Delivery: A Rare Case of Gonococcal PerihepatitisSARIAY N. İ., GÜLTEKİN M., GÜNEŞ A. C.
8. Diagnostic challenges in endometrial cancer: assessing the significance of insufficient biopsy results and the need for rebiopsyERZENEOĞLU B. E., EGE H. V., YAVUZ Ö. A., TEMİZ B. E., AKGÖR U., BAŞARAN D., et al.
9. Investigating vulvar lichen sclerosus and high-risk oncogenic HPV associationERZENEOĞLU B. E., TEMİZ B. E., EGE H. V., BAŞARAN D., GÜLTEKİN M., ÖZGÜL N.
10. High-Risk Oncogenic HPV Prevalence in Women with Vulvar Pruritus: A Prospective Comparative StudyERZENEOĞLU B. E., TEMİZ B. E., EGE H. V., BAŞARAN D., GÜLTEKİN M., ÖZGÜL N.
11. A practical approach for patient preparation prior to surgery in minimal invasive surgeryEGE H. V., ÖZGÜL N., GÜLTEKİN M., ERZENEOĞLU B. E., GÜNGÖR B., BAŞARAN D.
12. The role of office hysteroscopy in the diagnosis of symptomatic or asymptomatic patient groups in the premenopausal and postmenopausal periodsgüngör b., TEMİZ B. E., ERZENEOĞLU B. E., EGE H. V., BAŞARAN D., ÖZGÜL N., et al.
13. The need for vulvar biopsy in women with chronic itching: a single-center studyERZENEOĞLU B. E., TEMİZ B. E., BAŞARAN D., EGE H. V., Atakul M. o., Yavuz Ö. A., et al.
14. The role of office hysteroscopy in symptomatic or asymptomatic patients in the postmenopausal periodTEMİZ B. E., ERZENEOĞLU B. E., ÇABUKOĞLU F., AKDENİZ DERMAN E., EGE H. V., BAŞARAN D., et al.
15. Treatment outcomes of definitive or postoperative radiotherapy in elderly cervical cancer patientsGuler O. C., Sari S. Y., Birge S. D., GÜLTEKİN M., Yildiz F., Onal C.